Evidence map›Paper›PMID 37735597›Full record

ArticleNature cell biology2023

Defining E3 ligase-substrate relationships through multiplex CRISPR screening.

Richard T Timms, Elijah L Mena, Yumei Leng, Mamie Z Li, Iva A Tchasovnikarova, Itay Koren, Stephen J Elledge

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. AbioRxiv : the preprint server for biology · 2026
    Article
  6. Localized heme sensing through a ternary molecular glue.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Richard T Timms *Department of Genetics, Harvard Medical School, Division of Genetics, Brigham asnd Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7275-597X
Elijah L Mena *Department of Genetics, Harvard Medical School, Division of Genetics, Brigham asnd Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Yumei LengDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham asnd Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Mamie Z LiDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham asnd Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Iva A TchasovnikarovaWellcome/CRUK Gurdon Institute, Department of Biochemistry, University of Cambridge, Cambridge, UK.
Itay KorenThe Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.ORCID http://orcid.org/0000-0002-5693-1651
Stephen J ElledgeDepartment of Genetics, Harvard Medical School, Division of Genetics, Brigham asnd Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA. selledge@genetics.med.harvard.edu.ORCID http://orcid.org/0000-0001-7923-6283
Howard Hughes Medical Institute · USBar-Ilan University · ILUniversity of Cambridge · GB

Funding

Ubiquitin Mediated Proteolysis and Cell Cycle ControlR01AG011085 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JEFFREY W HARPER · 1993 to 2026
$10.9M
Characterization of a ubiquitin-independent pathway for proteasomal degradationK99AG081456 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI MENA, ELIJAH L · 2023 to 2024
$273k
European Research Council 947709Howard Hughes Medical InstituteNIA NIH HHS K99 AG081456NIA NIH HHS R01 AG011085Wellcome TrustWellcome Trust 201387/Z/16/Z
6 · The paper itself

Abstract

Specificity within the ubiquitin-proteasome system is primarily achieved through E3 ubiquitin ligases, but for many E3s their substrates-and in particular the molecular features (degrons) that they recognize-remain largely unknown. Current approaches for assigning E3s to their cognate substrates are tedious and low throughput. Here we developed a multiplex CRISPR screening platform to assign E3 ligases to their cognate substrates at scale. A proof-of-principle multiplex screen successfully performed ~100 CRISPR screens in a single experiment, refining known C-degron pathways and identifying an additional pathway through which Cul2

Indexed as

Proteasome Endopeptidase ComplexUbiquitin-Protein LigasesClustered Regularly Interspaced Short Palindromic RepeatsUbiquitinProteasome Endopeptidase ComplexUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID37735597
PMCPMC10567573
OpenAlexW4386923984

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.